160 related articles for article (PubMed ID: 21837324)
21. A PLGA nanofiber microfluidic device for highly efficient isolation and release of different phenotypic circulating tumor cells based on dual aptamers.
Wu Z; Pan Y; Wang Z; Ding P; Gao T; Li Q; Hu M; Zhu W; Pei R
J Mater Chem B; 2021 Mar; 9(9):2212-2220. PubMed ID: 33616137
[TBL] [Abstract][Full Text] [Related]
22. EpCAM-Independent Enrichment of Circulating Tumor Cells in Metastatic Breast Cancer.
Schneck H; Gierke B; Uppenkamp F; Behrens B; Niederacher D; Stoecklein NH; Templin MF; Pawlak M; Fehm T; Neubauer H;
PLoS One; 2015; 10(12):e0144535. PubMed ID: 26695635
[TBL] [Abstract][Full Text] [Related]
23. Magnetic particles assisted capture and release of rare circulating tumor cells using wavy-herringbone structured microfluidic devices.
Shi W; Wang S; Maarouf A; Uhl CG; He R; Yunus D; Liu Y
Lab Chip; 2017 Sep; 17(19):3291-3299. PubMed ID: 28840927
[TBL] [Abstract][Full Text] [Related]
24. High purity microfluidic sorting and analysis of circulating tumor cells: towards routine mutation detection.
Autebert J; Coudert B; Champ J; Saias L; Guneri ET; Lebofsky R; Bidard FC; Pierga JY; Farace F; Descroix S; Malaquin L; Viovy JL
Lab Chip; 2015 May; 15(9):2090-101. PubMed ID: 25815443
[TBL] [Abstract][Full Text] [Related]
25. Nanoparticle-mediated binning and profiling of heterogeneous circulating tumor cell subpopulations.
Mohamadi RM; Besant JD; Mepham A; Green B; Mahmoudian L; Gibbs T; Ivanov I; Malvea A; Stojcic J; Allan AL; Lowes LE; Sargent EH; Nam RK; Kelley SO
Angew Chem Int Ed Engl; 2015 Jan; 54(1):139-43. PubMed ID: 25377874
[TBL] [Abstract][Full Text] [Related]
26. Immunocapture of prostate cancer cells by use of anti-PSMA antibodies in microdevices.
Santana SM; Liu H; Bander NH; Gleghorn JP; Kirby BJ
Biomed Microdevices; 2012 Apr; 14(2):401-7. PubMed ID: 22143878
[TBL] [Abstract][Full Text] [Related]
27. Surface marker epithelial cell adhesion molecule and E-cadherin facilitate the identification and selection of induced pluripotent stem cells.
Chen HF; Chuang CY; Lee WC; Huang HP; Wu HC; Ho HN; Chen YJ; Kuo HC
Stem Cell Rev Rep; 2011 Sep; 7(3):722-35. PubMed ID: 21305366
[TBL] [Abstract][Full Text] [Related]
28. Automated Microfluidic Filtration and Immunocytochemistry Detection System for Capture and Enumeration of Circulating Tumor Cells and Other Rare Cell Populations in Blood.
Pugia M; Magbanua MJM; Park JW
Methods Mol Biol; 2017; 1634():119-131. PubMed ID: 28819845
[TBL] [Abstract][Full Text] [Related]
29. Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research.
Grover PK; Cummins AG; Price TJ; Roberts-Thomson IC; Hardingham JE
Ann Oncol; 2014 Aug; 25(8):1506-16. PubMed ID: 24651410
[TBL] [Abstract][Full Text] [Related]
30. Microfluidic, label-free enrichment of prostate cancer cells in blood based on acoustophoresis.
Augustsson P; Magnusson C; Nordin M; Lilja H; Laurell T
Anal Chem; 2012 Sep; 84(18):7954-62. PubMed ID: 22897670
[TBL] [Abstract][Full Text] [Related]
31. Channel surface patterning of alternating biomimetic protein combinations for enhanced microfluidic tumor cell isolation.
Launiere C; Gaskill M; Czaplewski G; Myung JH; Hong S; Eddington DT
Anal Chem; 2012 May; 84(9):4022-8. PubMed ID: 22482510
[TBL] [Abstract][Full Text] [Related]
32. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
[TBL] [Abstract][Full Text] [Related]
33. An integrated centrifugo-opto-microfluidic platform for arraying, analysis, identification and manipulation of individual cells.
Burger R; Kurzbuch D; Gorkin R; Kijanka G; Glynn M; McDonagh C; Ducrée J
Lab Chip; 2015 Jan; 15(2):378-81. PubMed ID: 25407668
[TBL] [Abstract][Full Text] [Related]
34. Ex vivo and in vivo capture and deactivation of circulating tumor cells by dual-antibody-coated nanomaterials.
Xie J; Gao Y; Zhao R; Sinko PJ; Gu S; Wang J; Li Y; Lu Y; Yu S; Wang L; Chen S; Shao J; Jia L
J Control Release; 2015 Jul; 209():159-69. PubMed ID: 25933713
[TBL] [Abstract][Full Text] [Related]
35. Analysis of the specificity and selectivity of anti-EpCAM antibodies in breast cancer cell lines.
Sterzynska K; Kempisty B; Zawierucha P; Zabel M
Folia Histochem Cytobiol; 2012; 50(4):534-41. PubMed ID: 23264216
[TBL] [Abstract][Full Text] [Related]
36. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients.
Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C
Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508
[TBL] [Abstract][Full Text] [Related]
37. Detachment of captured cancer cells under flow acceleration in a bio-functionalized microchannel.
Cheung LS; Zheng X; Stopa A; Baygents JC; Guzman R; Schroeder JA; Heimark RL; Zohar Y
Lab Chip; 2009 Jun; 9(12):1721-31. PubMed ID: 19495456
[TBL] [Abstract][Full Text] [Related]
38. Comparative study on antibody immobilization strategies for efficient circulating tumor cell capture.
Ates HC; Ozgur E; Kulah H
Biointerphases; 2018 Mar; 13(2):021001. PubMed ID: 29571263
[TBL] [Abstract][Full Text] [Related]
39. Microtube device for selectin-mediated capture of viable circulating tumor cells from blood.
Hughes AD; Mattison J; Western LT; Powderly JD; Greene BT; King MR
Clin Chem; 2012 May; 58(5):846-53. PubMed ID: 22344286
[TBL] [Abstract][Full Text] [Related]
40. Advances and critical concerns with the microfluidic enrichments of circulating tumor cells.
Hyun KA; Jung HI
Lab Chip; 2014 Jan; 14(1):45-56. PubMed ID: 23982141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
